Friday, 27 February 2015

Novartis lung cancer drug gets EU recommendation

LONDON (Reuters) - European health regulators said on Friday they had recommended approval of a drug for advanced lung cancer developed by Swiss drugmaker Novartis that is intended to treat patients with a specific genetic mutation.















via Reuters: Health News Read More Here..

No comments:

Post a Comment